Skip to main content
. 2022 Mar 29;55(9):1116–1127. doi: 10.1111/apt.16914

TABLE 2.

Summary results for each study group and period

Period 1 Period 2 Period 3 Statistical tests: Fixed effects
Gluten Control Washout Gluten Control Period*group Period Group
Primary outcome p‐values p‐values p‐values
Average VAS, 0‐100 mm 24.4 (2.2) 21.8 (2.2) 17.5 (1.9) 19.6 (2.2) 22.1 (2.2) 0.15 0.03 0.99
Key secondary outcomes
SF‐36 Mental Component Score, score: 0–100 48.3 (1.7) 48.7 (1.6) 48.5 (1.3) 51.4 (1.6) 49.5 (1.8) 0.52 0.10 0.54
SF‐36 Physical Component Score, score: 0‐100g 51.0 (0.8) 51.5 (0.8) 51.8 (0.6) 50.7 (0.8) 52.2 (0.8) 0.59 0.73 0.69
WEMWBS: 14–70 50.4 (1.3) 51.9 (1.1) 51.9 (0.8) 51.9 (1.1) 52.3 (1.2) 0.67 0.28 0.28
Other secondary outcomes
VAS1 / Abdominal pain, 0‐100 mm 29.1 (3.5) 18.4 (3.3) 17.7 (2.9) 19.0 (3.4) 28.0 (3.5) 0.00 0.90 0.65
VAS2 / Bloating, 0‐100 mm 37.4 (4.1) 30.7 (4.0) 25.8 (3.6) 29.2 (4.0) 34.5 (4.1) 0.07 0.27 0.73
VAS3 / Flatulence, 0‐100 mm 34.9 (3.8) 32.6 (3.7) 26.3 (3.3) 30.6 (3.7) 32.7 (3.9) 0.51 0.31 0.97
VAS4 / Borborygmi 0‐100 mm 23.2 (3.4) 27.1 (3.4) 18.6 (3.0) 23.7 (3.4) 19.5 (3.4) 0.15 0.04 0.92
VAS5 / Diarrhoea 0‐100 mm 15.9 (2.9) 13.5 (2.9) 11.9 (2.5) 14.6 (3.0) 15.8 (3.1) 0.53 0.77 0.72
VAS6 / Constipation 0‐100 mm 20.6 (3.2) 20.0 (3.1) 14.8 (2.7) 13.8 (3.2) 16.1 (3.2) 0.62 0.00 0.64
VAS7 / Incomplete evacuation after toilet visit, 0‐100 mm 29.4 (3.9) 28.0 (3.8) 26.2 (3.3) 28.7 (3.8) 38.3 (3.9) 0.09 0.02 0.04
VAS8 / Nausea, 0‐100 mm 29.0 (3.7) 20.5 (3.6) 16.2 (3.1) 17.9 (3.6) 22.5 (3.7) 0.05 0.02 0.34
VAS9 / Burping, 0‐100 mm 12.8 (2.5) 18.4 (2.5) 10.9 (2.2) 12.0 (2.5) 6.3 (2.6) 0.01 <0.00 0.97
VAS10 / dyspepsia, 0‐100 mm 11.0 (2.1) 12.2 (2.0) 6.8 (1.7) 8.3 (2.0) 6.7 (2.1) 0.47 0.00 0.87

Notes: Values are Least‐Squares Means (SE) unless otherwise stated.

Statistical tests are based on a repeated‐measures linear mixed‐effects model (participants modelled as a random effects variable).